X Biopharma Ltd. (SG:42C) has released an update. iX Biopharma Ltd. announced that its novel semaglutide sublingual wafer, iXB 401, achieved 20 ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Glucagon-like peptide-1 (GLP-1) agonist are a family of medications that help manage blood sugar in patients with type 2 ...

A surprise amount of Brits say they would take anti-obesity drugs if they were given to them for free on the ...

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British ...

There’s no hard-and-fast rule for how long it’s safe to stay on Ozempic for weight loss. Novo Nordisk-sponsored studies lasting up to two years show that semaglutide is safe.

Dividing the drug candidates by condition type, 129.2 million could benefit from semaglutide for weight control, 35 million ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Ozempic, Wegovy and Mounjaro are often the most popular weight loss drugs. While these medications help people lose weight, ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

Since the discovery of statins and the Scandinavian Simvastatin Survival Study (4S) results three decades ago, remarkable advances have been made in the treatment of dyslipidaemia, a major risk factor ...